Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Ewer

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 28, 2007
The anthracycline-trastuzumab interaction: Up-regulated binding may provide vital mechanistic insightMichael S Ewer
Pediatric Blood & Cancer|May 6, 2004
Exercise echocardiography reflects cumulative anthracycline exposure during childhoodMichael S Ewer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2021
Reply to K. Anand et al and K. KunimasaMichael S Ewer
Cardio-Oncology (London, England)|July 19, 2022
Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reportsMichael S Ewer, Jay Herson
Cancer|February 24, 2009
A woman's heart: the impact of adjuvant endocrine therapy on cardiovascular healthMichael S Ewer, Stefan Glück
Cardio-Oncology (London, England)|February 27, 2025
Is the pendulum slowly starting to swing back?Michael S Ewer, Jay Herson
Nature Reviews. Cardiology|August 21, 2015
Cardiotoxicity of anticancer treatmentsMichael S Ewer, Steven M Ewer
Expert Review of Anticancer Therapy|October 6, 2006
Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugsRobin L Jones, Michael S Ewer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2008
Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground?Michael S Ewer, Daniel J Lenihan
Nature Clinical Practice. Oncology|January 24, 2008
Is trastuzumab associated with adverse cardiac effects in patients with breast cancer?Michael S Ewer, Daniel J Lenihan
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|August 28, 2007
The anthracycline-trastuzumab interaction: Up-regulated binding may provide vital mechanistic insightMichael S Ewer
Pediatric Blood & Cancer|May 6, 2004
Exercise echocardiography reflects cumulative anthracycline exposure during childhoodMichael S Ewer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 23, 2021
Reply to K. Anand et al and K. KunimasaMichael S Ewer
Cardio-Oncology (London, England)|July 19, 2022
Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reportsMichael S Ewer, Jay Herson
Cancer|February 24, 2009
A woman's heart: the impact of adjuvant endocrine therapy on cardiovascular healthMichael S Ewer, Stefan Glück
Cardio-Oncology (London, England)|February 27, 2025
Is the pendulum slowly starting to swing back?Michael S Ewer, Jay Herson
Nature Reviews. Cardiology|August 21, 2015
Cardiotoxicity of anticancer treatmentsMichael S Ewer, Steven M Ewer
Expert Review of Anticancer Therapy|October 6, 2006
Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugsRobin L Jones, Michael S Ewer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2008
Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground?Michael S Ewer, Daniel J Lenihan
Nature Clinical Practice. Oncology|January 24, 2008
Is trastuzumab associated with adverse cardiac effects in patients with breast cancer?Michael S Ewer, Daniel J Lenihan
Pageof 8